Asheesh Bhatnagar

Director

The global biotechnology market is projected to reach $ 3,210.71 billion by 2030, driving a surge in the Indian healthcare sector. With this growth trajectory at hand, the Indian hospital market, which is valued at over $100 billion, offers significant opportunities for critical care specialists players in this niche space. However, the space is plagued with small unorganized players who only focus on revenue generation, impacting both established companies and hospitals who prioritizes long-term quality assurance.

Incorporated in August 2021, Questus Pharma embarked on its noteworthy journey with a core focus on the critical care segment. Within this niche, the company’s primary clientele consists of hospitals, corporate healthcare facilities, and standalone nursing homes, where the demand for injectables remains consistently high.

“We understand that meeting and exceeding the expectations of our clients is paramount. What our clients, particularly prospective partners, expect from us is a combination of quality and affordability. At Questus Pharma, we have meticulously crafted our offerings to ensure not only competitive pricing but also uncompromising quality standards. Our commitment extends beyond mere transactions; we strive to be true partners to our clients, anticipating their needs and providing comprehensive solutions”, highlights Asheesh Bhatnagar, Director at Questus Pharma.

“Questus Pharma remains steadfast in its dedication to quality, innovation, and customer satisfaction. We recognize the evolving needs of our clients and continuously adapt our strategies to meet and exceed their expectations. By offering an extensive range of high-quality injectables, coupled with personalized service and competitive pricing, we aim to not only meet but also surpass the expectations of our clients in the critical care segment,” he adds.

Since its inception in 2021, Questus Pharma has positioned itself as a promising partner in critical care pharmaceuticals. Focused on delivering high-quality injectables to hospitals, the company’s mission is reflected in its name, ‘Questus’, which symbolizes its commitment to collective success.

“Furthermore, with a goal of reaching 100 crores in revenue within five years, we started with a portfolio of over 100 SKUs. In 2021, we surpassed expectations, achieving 40 crores in revenue, thanks to our dedication to quality and innovation. Our in-house R&D division, launched alongside our operations, drives continuous improvement and tailors solutions to industry needs. Strategic partnerships have led to collaborations with major healthcare chains of India, showcasing trust in Questus Pharma,” signifies Asheesh.

Ensuring Utmost Quality Standards

Quality assurance is paramount at Questus Pharma, especially in injectable manufacturing. Every step, from formulation to release, is meticulously monitored to maintain excellence. The company’s dedicated R&D team collaborates closely with manufacturing, ensuring stringent standards throughout. Samples from each batch undergo thorough testing at its advanced R&D facility before market release.

At Questus Pharma, quality is a relentless pursuit, driving us to set new benchmarks for excellence. Questus carries out an in-depth testing process which ensures only high-quality products bear the Questus Pharma name. Thereby, fostering trust among customers and partners.

Questus Pharma’s strict adherence to regulatory standards, further ensures optimal quality standards. Furthermore, the company has been actively seeking additional international accreditations to bolster its commitment to quality. Furthermore, Asheesh brings over 30 years of industry experience, which has greatly helped the company to garner in-depth understanding of the critical care and hospital landscape.

“Each client engagement is personalized and consultative. We take time to understand their needs, preferences, and specialty areas, whether in cardiac care, oncology, or other disciplines. Engagements involve thorough discussions and negotiations, ensuring alignment with client needs, competitive pricing, and uncompromising quality. This collaborative approach builds mutual understanding and trust, forming the basis for long-term partnerships. Throughout, our commitment to delivering exceptional service and tailored solutions remains unwavering, meeting evolving client needs,” explains Asheesh.

Setting New Standards in Critical Care Pharmaceuticals

Questus Pharma’s unparalleled range of over 100 SKUs in the first year of its launch, spanning critical care areas such as cardiac care, antifungals, anesthesia, antibiotics, and more, distinguishes it as one of the most comprehensive providers of critical care solutions.

Furthermore, quality assurance is ingrained in every aspect of Questus Pharma’s everyday operations. From stringent manufacturing processes to thorough testing protocols, the company ensures that only the highest quality products reach its clients. Moreover, the company’s commitment to innovation drives in continually expanding its product portfolio while exploring new avenues for growth. In addition, the company prioritizes building long-lasting relationships with its clients, focusing on consistency, reliability, and exceptional service. And since inception, Questus Pharma has achieved notable growth and recognition in critical care pharmaceuticals.

“Going forward, our roadmap includes ambitious yet attainable goals. We aim to be a top-five critical care company, targeting revenues of 100 crores by 2026 while developing staggering 120+ SKUs. Our vision extends beyond finances to fostering a cohesive team environment centered on excellence and customer satisfaction. Innovation drives our growth strategy, with continued investment in R&D, product expansion, and new market exploration. With a focus on quality, innovation, and customer-centricity, we are poised for success in driving positive change in the industry,” concludes Asheesh.